Form 4 for ALZN Alzamend Neuro, Inc.
Accepted 2025-10-24 00:00:00 ET · period of report 2025-10-23 · accession 0001214659-25-015288 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-24 | 2025-10-23 | ALZN | McGrath Lynne Fahey | Dir | S - Sale | $2.29 | -30 | 25 | -55% | -$68.70 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-23 | S | D | 30 | $2.29 | 25 | D | — | — |